KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Accumulated Expenses (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Accumulated Expenses for 9 consecutive years, with $206.0 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 16.38% to $206.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $206.0 million through Dec 2025, up 16.38% year-over-year, with the annual reading at $206.0 million for FY2025, 16.38% up from the prior year.
  • Accumulated Expenses hit $206.0 million in Q4 2025 for Elanco Animal Health, up from $177.0 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $206.0 million in Q4 2025 to a low of $110.0 million in Q1 2023.
  • Historically, Accumulated Expenses has averaged $144.8 million across 5 years, with a median of $141.0 million in 2022.
  • Biggest five-year swings in Accumulated Expenses: soared 116.78% in 2021 and later dropped 21.08% in 2022.
  • Year by year, Accumulated Expenses stood at $185.0 million in 2021, then fell by 21.08% to $146.0 million in 2022, then grew by 7.53% to $157.0 million in 2023, then increased by 12.74% to $177.0 million in 2024, then increased by 16.38% to $206.0 million in 2025.
  • Business Quant data shows Accumulated Expenses for ELAN at $206.0 million in Q4 2025, $177.0 million in Q4 2024, and $157.0 million in Q4 2023.